Methods for the treatment of renal cell carcinoma

Details for Australian Patent Application No. 2004216245 (hide)

Owner Genentech Inc.

Inventors Gerritsen, Mary E.; Peale, Franklin V. Jr.; Wu, Thomas D.

Agent Griffith Hack

Pub. Number AU-A-2004216245

PCT Pub. Number WO2004/075835

Priority 10/372,683 21.02.03 US

Filing date 20 February 2004

Wipo publication date 10 September 2004

International Classifications

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/075835 Priority application(s): WO2004/075835

29 September 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Genentech Inc. to Genentech, Inc.

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216246-Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis

2004216244-Biopsy device with inner cutting member